The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AUPH FINANCIAL STATEMENTS

Aurinia Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

AUPHAurinia Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue311.5 M $Gross Profit281.5 M $ · 90%Operating Income150.7 M $ · 48%Pre-tax Income160.4 M $ · 51%Net Income to Owners314.1 M $ · 101%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue311.5 M $+19.8%
Gross Profit281.5 M $+20.9%
Operating Income150.7 M $+189.8%
EBITDA188.2 M $+117.6%
Net Income to Owners314.1 M $+418.0%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets792.3 M
  • Equity614.9 M $78%
  • Current Liabilities99.9 M $13%
  • Long-term Liabilities77.5 M $10%

Key Figures

YoY change
Total Assets792.3 M $+57.6%
Total Liabilities177.4 M $+6.1%
Total Equity614.9 M $+83.4%
Cash & ST Investments443.1 M $+40.6%
Total Debt60.4 M $-26.2%
Net Debt-119.4 M $-514.2%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M174.1 M $Operating12.7 M $Investing-59.9 M $Financing127 M $Net Change

Key Figures

YoY change
Operating Cash Flow174.1 M $+87.9%
Capital Expenditures212.8 K $-16.9%
Free Cash Flow206.5 M $+123.4%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AUPH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.